These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1077 related articles for article (PubMed ID: 16279780)
1. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents. Gangjee A; Lin X; Kisliuk RL; McGuire JJ J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780 [TBL] [Abstract][Full Text] [Related]
2. Benzoyl ring halogenated classical 2-amino-6-methyl-3,4-dihydro-4-oxo-5-substituted thiobenzoyl-7H-pyrrolo[2,3-d]pyrimidine antifolates as inhibitors of thymidylate synthase and as antitumor agents. Gangjee A; Jain HD; McGuire JJ; Kisliuk RL J Med Chem; 2004 Dec; 47(27):6730-9. PubMed ID: 15615522 [TBL] [Abstract][Full Text] [Related]
3. Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates(1). Gangjee A; Jain HD; Phan J; Lin X; Song X; McGuire JJ; Kisliuk RL J Med Chem; 2006 Feb; 49(3):1055-65. PubMed ID: 16451071 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and X-ray crystal structure of a potent dual inhibitor of thymidylate synthase and dihydrofolate reductase as an antitumor agent. Gangjee A; Yu J; McGuire JJ; Cody V; Galitsky N; Kisliuk RL; Queener SF J Med Chem; 2000 Oct; 43(21):3837-51. PubMed ID: 11052789 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological activities of classical N-[4-[2-(2-amino-4-ethylpyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and its 6-methyl derivative as potential dual inhibitors of thymidylate synthase and dihydrofolate reductase and as potential antitumor agents. Gangjee A; Yu J; Kisliuk RL; Haile WH; Sobrero G; McGuire JJ J Med Chem; 2003 Feb; 46(4):591-600. PubMed ID: 12570380 [TBL] [Abstract][Full Text] [Related]
6. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines. Gangjee A; Adair O; Queener SF J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486 [TBL] [Abstract][Full Text] [Related]
7. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases. Gangjee A; Vasudevan A; Queener SF; Kisliuk RL J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents. Gangjee A; Adair OO; Queener SF J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957 [TBL] [Abstract][Full Text] [Related]
10. 2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors. Gangjee A; Jain HD; Phan J; Guo X; Queener SF; Kisliuk RL Bioorg Med Chem; 2010 Jan; 18(2):953-61. PubMed ID: 20056546 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors. Gangjee A; Li W; Yang J; Kisliuk RL J Med Chem; 2008 Jan; 51(1):68-76. PubMed ID: 18072727 [TBL] [Abstract][Full Text] [Related]
12. Novel 2-amino-4-oxo-5-arylthio-substituted-pyrrolo[2,3-d]pyrimidines as nonclassical antifolate inhibitors of thymidylate synthase. Gangjee A; Jain HD; Kisliuk RL Bioorg Med Chem Lett; 2005 May; 15(9):2225-30. PubMed ID: 15837298 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents. Gangjee A; Li W; Kisliuk RL; Cody V; Pace J; Piraino J; Makin J J Med Chem; 2009 Aug; 52(15):4892-902. PubMed ID: 19719239 [TBL] [Abstract][Full Text] [Related]
14. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents. Robson C; Meek MA; Grunwaldt JD; Lambert PA; Queener SF; Schmidt D; Griffin RJ J Med Chem; 1997 Sep; 40(19):3040-8. PubMed ID: 9301666 [TBL] [Abstract][Full Text] [Related]
15. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity. Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of tricyclic conformationally restricted tetrahydropyrido annulated furo[2,3-d]pyrimidines as inhibitors of dihydrofolate reductases. Gangjee A; Elzein E; Queener SF; McGuire JJ J Med Chem; 1998 Apr; 41(9):1409-16. PubMed ID: 9554874 [TBL] [Abstract][Full Text] [Related]